When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GWPH - Where Will GW Pharmaceuticals Be in 1 Year?
GW Pharmaceuticals Plc
Almost two years ago, the U.S. Food and Drug Administration (FDA) approved the first-ever cannabinoid-derived drug, created by GW Pharmaceuticals(NASDAQ: GWPH). The drug is called Epidolex and is used to treat patients with severe drug-resistant seizures that begin during childhood.
Since its approval, sales of Epidolex have been skyrocketing, and I think the momentum is far from over. Within the next year, Epidolex has opportunities lined up for both label expansion and international expansion. Let's take a look at these opportunities.